ARHGAP29 |
Rho GTPase activating protein 29 |
chr1:094477485–094477544 |
−(1590–1649) |
Signal transduction, candidate tumor suppressor gene in MCL |
4.35 |
BC033172 |
Hypothetical protein |
chr4:183299087–183299133 |
3’ end +(664–710) |
Function unknown |
1.66 |
BRDG1 |
Signal transducing adaptor family member 1 |
chr4:068107287–068107346 |
+(246–305) |
Downstream of Tec tyrosine kinase in B cell antigen receptor signaling |
149.01 |
C1orf188 |
Ring finger protein 207 |
chr1:006191778–006191822 |
+(3002–3046) |
Function unknown |
1.28 |
CADPS2 |
Ca2+-dependent activator protein for secretion 2 |
chr7:122313589–122313633 |
+(157–201) |
Calcium ion binding, exocytosis protein transport. It is related to hyperactive behavior and autism |
1.29 |
CDC25A |
Cell division cycle 25A |
chr3:48205294–48205338 |
−(489–533) |
CDC25A is required for G1/S and G2/M transition. It is an oncogene |
3.26 |
CDKN2AIP |
CDKN2A (p16) interacting protein |
chr4:184602132–184602177 |
−(651–606) |
Binds to p16, p53, and HDM2, and involved in cell cycle, senescence, and DNA damage response |
2.88 |
CX3CL1 |
Chemokine (C-X3-C motif) ligand 1 |
chr16:55964583–55964627 |
+(668–712) |
Mediates antitumor immune response |
1.97 |
DNAH2 |
Dynein, axonemal, heavy chain 2 |
chr17:7556327–7556371 |
+(7437–7393) |
Belongs to dyneins protein family, components of multisubunit motor ATPase complexes |
88.65 |
ELF4 |
E74-like factor 4 |
chrX:129072521–129072565 |
−(368–412) |
Transcription factor. Candidate tumor suppressor gene, regulates cell cycle entry |
14.38 |
GNAL |
Guanine nucleotide binding protein, alpha activating |
chr18:11738236–11738288 |
+(58972–59025) |
Cellular transformation and tumor development |
1.92 |
KDELR1 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1 |
chr19:53589176–53589220 |
−(2554–2598) |
Intracellular signal transduction, deleted in gliomas |
2.10 |
POU4F2 |
POU class 4 homeobox 2 |
chr4:147779300–147779344 |
−(151–195) |
Transcription factor expressed in human retina ganglion cells. Regulates CDK4, CCND1, and it facilitates breast cancer progression and invasion |
1.61 |
RD3 |
Retinal degeneration 3 |
chr1:209731637–209731681 |
+(1201–1245) |
Gene transcription and splicing |
1.13 |
REN |
Renin |
chr1:202402110–202402165 |
−(22–77) |
Involved in angiotensin maturation, regulation of blood pressure |
1.35 |
THRA |
Thyroid hormone receptor, alpha |
chr17:35473541–35473585 |
+(952–996) |
Mediates activities of thyroid hormone, expression level altered in thyroid and breast cancer |
17.63 |